Secukinumab Efficacy on Enthesitis in Patients With Ankylosing Spondylitis: Pooled Analysis of Four Pivotal Phase III Studies
Schett G, Baraliakos X, Van Den Bosch F, Deodhar A, Ostergaard M, Das Gupta A, Mpofu S, Fox T, Winseck A, Porter B, Shete A, Gensler LS (2021)
Publication Type: Journal article
Publication year: 2021
Journal
Book Volume: 48
Pages Range: 1251-1258
Journal Issue: 8
Abstract
Objective: To assess the efficacy of secukinumab on axial and peripheral enthesitis in patients with ankylosing spondylitis (AS) using pooled data from randomized controlled phase III studies.
Authors with CRIS profile
Involved external institutions
Ruhr-Universität Bochum (RUB)
Germany (DE)
Universiteit Gent (UGent) / Ghent University
Belgium (BE)
Oregon Health and Science University (OSHU)
United States (USA) (US)
University of Copenhagen
Denmark (DK)
Novartis AG
Switzerland (CH)
University of California San Francisco (UCSF)
United States (USA) (US)
Germany (DE)
Universiteit Gent (UGent) / Ghent University
Belgium (BE)
Oregon Health and Science University (OSHU)
United States (USA) (US)
University of Copenhagen
Denmark (DK)
Novartis AG
Switzerland (CH)
University of California San Francisco (UCSF)
United States (USA) (US)
How to cite
APA:
Schett, G., Baraliakos, X., Van Den Bosch, F., Deodhar, A., Ostergaard, M., Das Gupta, A.,... Gensler, L.S. (2021). Secukinumab Efficacy on Enthesitis in Patients With Ankylosing Spondylitis: Pooled Analysis of Four Pivotal Phase III Studies. Journal of Rheumatology, 48(8), 1251-1258. https://dx.doi.org/10.3899/jrheum.201111
MLA:
Schett, Georg, et al. "Secukinumab Efficacy on Enthesitis in Patients With Ankylosing Spondylitis: Pooled Analysis of Four Pivotal Phase III Studies." Journal of Rheumatology 48.8 (2021): 1251-1258.
BibTeX: Download